INTRODUCTION AND OBJECTIVES: Despite improvements in medical care, surgical removal of failed transplant renal allografts may be mandated by sepsis, bleeding, pain, or erythropoietin resistance. Transplant nephrectomy has historically been performed in an open fashion by transplant surgeons and carries morbidity up to 50% with mortality up to 7%. To date, there is a single reported case of robot assisted transplant allograft nephrectomy from a deceased donor kidney. We herein present our series of robotic assisted transplant nephrectomy (RTN).
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METHODS: All patients who underwent robotic allograft nephrectomy at Mayo Clinic Arizona were included. Patients were not excluded for undergoing a concurrent procedure. All RTN were performed by a single Urologist (EPC) in conjunction with a single Transplant surgeon (NNK) via a transperitoneal approach utilizing a dual console Da Vinci Robotic Si/Xi surgical system. Study design was retrospective and observational. Variables analyzed included: demographics (age, BMI, ASA), comorbidities, transplant related (time from transplant to transplant nephrectomy, living related or deceased donor transplants), operative variables (operative time, estimated blood loss and additional procedures performed) peri-operative variables (length of stay (LOS), drain duration, Foley catheter duration, and hemoglobin change), and 30-day Clavien-Dindo complications. All variables were analyzed by non-parametric tests with commercially available software (SPSS vs, 21, Chicago, Illinois RESULTS: Six patients underwent RTN between 10/31/2014 until 4/31/2016. The time from transplant to transplant nephrectomy was a median of 5.9 years (range: 0.3 -40). The majority of transplants were from deceased donors (66%). The median operating time was 306 minutes (range: 178 e 532). Of note, in two of the six RTN cases bilateral laparoscopic native nephrectomies were performed and in a third case a robotic nephrectomy and a lymph node biopsy by plastic surgery was performed. There were no intraoperative complications or conversions to open nephrectomy. Estimated median blood loss was 150 mL (range: 100 e 400), with a transfusion rate of 16%. Drains were utilized in 84% of patients and for a median of 2 days. There were three minor complications.
CONCLUSIONS: In this first reported series of robotic transabdominal allograft nephrectomy we demonstrate the safety and feasibility of the use of robotic technology for transplant nephrectomy. This is a small series that includes our learning curve. KTx) recipients, which is much higher than that of normal people because of the repeated blood transfusion, dialysis, and immunosuppression. In current work, we aimed to perform a systematic review and meta-analysis to evaluate the efficacy and tolerability of sofosbuvir (SOF)-based Direct-Acting Antiviral Agents (DAAs) in KTx recipients.
METHODS: A systematic literature search of MEDLINE, EMBASE, The Cochrane Library, Web of Science, and ClinicalTrials.gov was performed to identify clinical trials evaluating SOF-based DAAs in KTx with HCV infection published or in press from 2012 to present. Effect sizes were collected as pooled event rates (sustained viral response, SVR12 or SVR4) with corresponding 95% CIs. All statistical analyses were conducted by R 3.3.1.
RESULTS: Eleven studies with a total of 360 KTx recipients were finally included. Most KTx recipients (88.1%) had HCV-1 infection. A total of 24 patients who received dual or combined organs transplants were reported. The overall rate of SVR12 reached 94% (95%CI: 88% to 97%). No significant heterogeneity was observed (p¼0.92). SVR4 reached 99% (95%CI: 93% to 100%). The clearance rate of HCV RNA at the end of treatment (EOT) (12 weeks) was 94% (95%CI: 87% to 97%). The rate of rapid virological response (RVR) was 73% (95%CI: 55% to 85%; I2¼58.9%, P¼0.045). The SOF-based DAAs did not impact the kidney function, whereas the liver enzyme parameters (such as ALT, ATS) had decreased during. The most frequent AEs were headache 6.9% (n¼25/360), asthenia 4.4% (n¼15/360), and fatigue 3.3% (n¼12/360).
CONCLUSIONS: In summary, our meta-analysis represented the first systematic review to evaluate the efficacy and safety of SOF-based DAAs in the post-KTx setting for a total of 360 patients from eleven individual studies. Data from current analysis suggest that SOF-based DAAs therapy is a highly effective treatment with an SVR12 rate (94%) and excellent tolerability, compared to prior interferon therapy for KTx recipients.
INTRODUCTION AND OBJECTIVES: Evaluating learning curve of a new procedure is important in order to assess the reproducibility and ease of adoption of the procedure, and also to track progress of an institution adopting the new procedure. This study reports the results and learning curves of robotic kidney transplantation (RKT) with regional hypothermia at a center that recently adopted this procedure.
METHODS: 33 patients underwent Vattikuti Urology Institute technique of RKT in Turkey, by surgeons routinely performing robotic surgery and kidney transplantation. Standard KT outcomes were noted Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e73
